A novel mechanism of toxic injury to the Papez circuit from chemotherapy

J Clin Neurosci. 2015 Apr;22(4):760-2. doi: 10.1016/j.jocn.2014.10.008. Epub 2015 Jan 3.

Abstract

Toxic effects of chemotherapy delivered via Ommaya reservoir include pericatheter necrosis and toxic leukoencephalopathy. Imaging evidence of toxicity is often asymptomatic, but can be clinically consequential. A young patient, treated for cerebrospinal fluid relapse of acute lymphoblastic leukemia with methotrexate and cytarabine via Ommaya reservoir, presented with acute deterioration of short-term memory. MRI demonstrated extra-ventricular Ommaya catheter position and typical methotrexate-induced changes in the deep white matter, but also signal alteration in the forniceal columns and mammillary bodies, components of the Papez circuit. This case presents a novel mechanism of chemotherapy-induced neurotoxicity associated with extra-ventricular Ommaya catheter position. Specifically, the clinical and imaging findings suggest that extra-ventricular Ommaya catheter position may lead to a direct methotrexate-induced toxicity to the Papez circuit. This provides further clinical evidence of the function of the circuit. The possibility that this patient received a supratherapeutic dose of methotrexate may explain why this presentation with profound memory impairment is not more common. However, this case also provides a potential explanation for patients who receive standard dose chemotherapy via extra-ventricular Ommaya catheter and develop milder memory loss.

Keywords: Ommaya reservoir; Papez circuit; Toxic leukoencephalopathy.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Brain / drug effects*
  • Brain / pathology
  • Cytarabine / administration & dosage
  • Cytarabine / adverse effects*
  • Cytarabine / therapeutic use
  • Drug Delivery Systems
  • Humans
  • Magnetic Resonance Imaging
  • Memory Disorders / chemically induced*
  • Memory Disorders / pathology
  • Methotrexate / administration & dosage
  • Methotrexate / adverse effects*
  • Methotrexate / therapeutic use
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / pathology

Substances

  • Cytarabine
  • Methotrexate